Avalyn Pharma found strong investor interest in its inhalable drugs in development for two types of pulmonary fibrosis, enabling the company to upsize its IPO. Data from two mid-stage studies are expected in 2027.
A year after Sarah Murnaghan’s parents successfully campaigned for her to receive an adult lung transplant, the group that manages organ transplant policy has permanently changed a rule to allow some children to be considered for adult lung transplants. The parents of Murnaghan, who has cystic fibrosis and diabetes from CF, successfully sued for their […]
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.